CNTA - Centessa Pharmaceuticals plc -  [ ]

Ticker Details
Centessa Pharmaceuticals plc
IPO Date: May 28, 2021
Sector: Healthcare
Industry: Biotech
Market Cap: $4.08B
Activated in VL: False
Average Daily Range
Avg Daily Range: $0.37 | 3.31%
Avg Daily Range (30 D): $0.68 | 2.54%
Avg Daily Range (90 D): $0.53 | 2.05%
Institutional Daily Volume
Avg Daily Volume: .44M
Avg Daily Volume (30 D): 1.22M
Avg Daily Volume (90 D): 1.3M
Trade Size
Avg Trade Size (Sh.): 111
Avg Trade Size (Sh.) (30 D): 104
Avg Trade Size (Sh.) (90 D): 101
Institutional Trades
Total Institutional Trades: 1,257
Avg Institutional Trade: $1.7M
Avg Institutional Trade (30 D): $1.96M
Avg Institutional Trade (90 D): $2.44M
Avg Institutional Trade Volume: .1M
Avg Institutional Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $1.45M
Avg Closing Trade (30 D): $1.68M
Avg Closing Trade (90 D): $2.03M
Avg Closing Volume: 68.25K
 
News
Apr 8, 2026 @ 4:02 PM
Looks Like M&A Week in 3 Different Sectors
Source: Motley Fool Staff
Apr 3, 2026 @ 2:35 PM
Deal Dispatch: McCormick, Unilever Merge, Sysco Ac...
Source: Caroline Ryan
Apr 2, 2026 @ 5:51 PM
Lilly’s Next Empire: A $10 Billion Bet on A...
Source: Jeffrey Neal Johnson
Mar 31, 2026 @ 11:43 PM
Nxera Pharma's Partner Centessa Pharmaceuticals to...
Source: Not Specified
Mar 31, 2026 @ 11:43 PM
Nxera Pharma’s Partner Centessa Pharmaceuti...
Source: Nxera Pharma
Financials
  TTM Q4 2025 FY 2025
Basic EPS $-1.46 $-.48 $-1.46
Diluted EPS $-1.46 $-.48 $-1.46
Revenue $15M $M $15M
Gross Profit
Net Income / Loss $-197.53M $-66.16M $-197.53M
Operating Income / Loss $-207.69M $-68.47M $-207.69M
Cost of Revenue
Net Cash Flow $-321.27M $11.14M $-321.27M
PE Ratio